423 related articles for article (PubMed ID: 10452989)
1. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA
J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989
[TBL] [Abstract][Full Text] [Related]
2. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
3. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
Chen FL; Kung JT
J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
[TBL] [Abstract][Full Text] [Related]
4. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
5. Membranes of activated CD4+ T cells expressing T cell receptor (TcR) alpha beta or TcR gamma delta induce IgE synthesis by human B cells in the presence of interleukin-4.
Gascan H; Aversa GG; Gauchat JF; Van Vlasselaer P; Roncarolo MG; Yssel H; Kehry M; Spits H; De Vries JE
Eur J Immunol; 1992 May; 22(5):1133-41. PubMed ID: 1349531
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
[TBL] [Abstract][Full Text] [Related]
7. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
8. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of cytokines on proliferative response of human CD4+ T lymphocyte subsets stimulated via T cell receptor-CD3 complex.
Wasik MA; Morimoto C
J Immunol; 1990 May; 144(9):3334-40. PubMed ID: 1691754
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.
Smith DM; Bluestone JA; Jeyarajah DR; Newberg MH; Engelhard VH; Thistlethwaite JR; Woodle ES
J Immunol; 1994 Aug; 153(3):1054-67. PubMed ID: 7913109
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
Li B; Bassiri H; Rossman MD; Kramer P; Eyuboglu AF; Torres M; Sada E; Imir T; Carding SR
J Immunol; 1998 Aug; 161(3):1558-67. PubMed ID: 9686624
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to CD44 trigger effector functions of human T cell clones.
Galandrini R; Albi N; Tripodi G; Zarcone D; Terenzi A; Moretta A; Grossi CE; Velardi A
J Immunol; 1993 May; 150(10):4225-35. PubMed ID: 8097750
[TBL] [Abstract][Full Text] [Related]
13. Activation induces apoptosis in Herpesvirus saimiri-transformed T cells independent of CD95 (Fas, APO-1).
Bröker BM; Kraft MS; Klauenberg U; Le Deist F; de Villartay JP; Fleckenstein B; Fleischer B; Meinl E
Eur J Immunol; 1997 Nov; 27(11):2774-80. PubMed ID: 9394798
[TBL] [Abstract][Full Text] [Related]
14. Differential response of CD4+ V7+ and CD4+ V7- T cells to T cell receptor-dependent signals: CD4+ V7+ T cells are co-stimulation independent and anti-V7 antibody blocks the induction of anergy by bacterial superantigen.
Soares LR; Rivas A; Ruegg C; Engleman EG
Eur J Immunol; 1997 Jun; 27(6):1413-21. PubMed ID: 9209493
[TBL] [Abstract][Full Text] [Related]
15. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
Hirohata S
Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
17. Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen.
Yagi J; Dianzani U; Kato H; Okamoto T; Katsurada T; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T
J Immunol; 1999 Sep; 163(6):3083-91. PubMed ID: 10477573
[TBL] [Abstract][Full Text] [Related]
18. Subset of CD4+ T cell clones expressing IL-3 receptor alpha-chains uses IL-3 as a cofactor in autocrine growth.
Mueller DL; Chen ZM; Schwartz RH; Gorman DM; Kennedy MK
J Immunol; 1994 Oct; 153(7):3014-27. PubMed ID: 7522247
[TBL] [Abstract][Full Text] [Related]
19. Induction of B cell apoptosis by TH0, but not TH2, CD4+ T cells.
He X; Zhong W; Goronzy JJ; Weyand CM
J Clin Invest; 1995 Feb; 95(2):564-70. PubMed ID: 7860739
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
Mukherjee S; Ahmed A; Malu S; Nandi D
J Leukoc Biol; 2006 Jul; 80(1):66-74. PubMed ID: 16624934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
